Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...

Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders ...

The state of clinical trials in the UK has been a central topic of discussion for some years now, but keenly so since Brexit ...

Novartis has unlocked another growth driver for its fast-growing breast cancer therapy Kisqali with EU approval as an ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

Just over a month after it was approved in the UK, AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development, quality ...

Medigene has said it will cut 40% of its workforce and delay the start of clinical trials of its lead asset as it re-jigs its ...

Medicare coverage would reduce out-of-pocket costs for AOMs – which can currently be as high as $1,000 a month - by as much ...